South Korea - Lipid Modifying Medicine Use
Since 2014, South Korea Lipid Modifying Medicine Use jumped by 7.3% year on year. In 2019, the country was ranked number 25 among other countries in Lipid Modifying Medicine Use with 74.1 Units (Defined Daily Dosage) Per Thousand Persons Per Day. South Korea is overtaken by Latvia, which was number 24 with 92.8 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Estonia at 69.1 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Denmark topped the ranking with 159.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, an increase of 3.5% compared to 2018. United Kingdom, Norway and Belgium respectively ranked number 2, 3 and 4 in this ranking. Lithuania witnessed the best average annual growth at +18.8% per year, while Slovakia recorded the worst performance at -8.7% per year.
Loading...
Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
---|---|
2019 | 74.10 |
2018 | 72.40 |
2017 | 67.40 |
2016 | 63.10 |
2015 | 58.80 |
How does South Korea rank in Lipid Modifying Medicine Use?
# | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Denmark
|
160 | 2019 | +3.5 % | +3.8 % | View data | |
2 |
#2
United Kingdom
|
153 | 2019 | +1.7 % | +2.3 % | View data | |
24 |
#24
Latvia
|
93 | 2019 | +9.8 % | +10.5 % | View data | |
25 |
#25
South Korea
|
74 | 2019 | +2.4 % | +7.3 % | View data | |
26 |
#26
Estonia
|
69 | 2019 | +7.3 % | +7.9 % | View data |